Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2025.08.29

NAV

14,558KRW

-89.49하락 (-0.61%)

Market Price per share (KRW)

14,540KRW

-120하락 (-0.82%)

※ t-1 last price

trading volume

14,142shares

AUM

KRW 29.8billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2025.08.29
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 29,843,119,566
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 14,540
※ t-1 last price 		14,557 14,142
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
29,843,119,566 하나은행
Market Price per share (KRW) iNAV per share (KRW)
14,540
※ t-1 last price 		14,557
Trading Volume (shares)
14,142
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2025-08-29
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion 10.24
2 Alteogen 9.93
3 SAMSUNG BIOLOGICS 9.53
4 Yuhan 9.16
5 PharmaResearch 6.63
6 HLB 6.29
7 LCB 5.53
8 ABL Bio 4.55
9 SCD 3.88
10 SKBP 3.86

proportion by sectors

*The proportion of investment stocks

Update : 2025.08.29
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2025-08-29

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV -4.52 6.99 -2.04 -3.04 29.68 4.23 43.54
Benchmark Index -4.60 7.10 -2.00 -3.18 29.24 4.42 44.48
Outperformance 0.08 -0.11 -0.05 0.14 0.44 -0.19 -0.94

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2025.08.29 14,540 -0.818하락 14,557.62 -0.610하락 10,355.26
2025.08.28 14,660 -0.508하락 14,647.11 -0.347하락 10,355.29
2025.08.27 14,735 -0.067하락 14,698.17 -0.495하락 10,355.34
2025.08.26 14,745 0.306상승 14,771.34 0.703상승 10,355.36
2025.08.25 14,700 1.835상승 14,668.1 1.589상승 10,355.39
2025.08.22 14,435 0.803상승 14,438.59 0.976상승 10,355.47
2025.08.21 14,320 0.034상승 14,298.94 -0.189하락 10,355.5
2025.08.20 14,315 -0.968하락 14,326.15 -1.186하락 10,355.53
2025.08.19 14,455 -1.833하락 14,498.18 -1.310하락 10,355.41
2025.08.18 14,725 -0.674하락 14,690.68 -0.986하락 10,355.45
2025.08.14 14,825 -0.134하락 14,837.15 0.114상승 10,355.61
2025.08.13 14,845 1.922상승 14,820.17 1.739상승 10,355.65
2025.08.12 14,565 -1.052하락 14,566.8 -0.833하락 10,355.68
2025.08.11 14,720 -0.033하락 14,689.2 -0.467하락 10,355.7
2025.08.08 14,725 -0.270하락 14,758.28 0.166상승 10,355.77
2025.08.07 14,765 -1.171하락 14,733.74 -1.140하락 10,355.8
2025.08.06 14,940 0.134상승 14,903.77 0.138상승 10,355.81
2025.08.05 14,920 2.261상승 14,883.2 2.102상승 10,355.84
2025.08.04 14,590 1.637상승 14,576.79 1.765상승 10,355.88
2025.08.01 14,355 -3.979하락 14,323.92 -4.443하락 10,356.11
2025.07.31 14,950 -0.960하락 14,989.98 -0.461하락 10,356
2025.07.30 15,095 -1.048하락 15,059.46 -1.225하락 10,356.03

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Celltrion KR7068270008 435 10.24 74,994,000
2 Alteogen KR7196170005 174 9.93 72,732,000
3 SAMSUNG BIOLOGICS KR7207940008 69 9.53 69,828,000
4 Yuhan KR7000100008 582 9.16 67,104,600
5 PharmaResearch KR7214450009 71 6.63 48,564,000
6 HLB KR7028300002 1,220 6.29 46,055,000
7 LCB KR7141080002 273 5.53 40,513,200
8 ABL Bio KR7298380007 352 4.55 33,334,400
9 SCD KR7000250001 145 3.88 28,420,000
10 SKBP KR7326030004 284 3.86 28,286,400
11 HanmiPharm KR7128940004 66 2.74 20,031,000
12 Hugel KR7145020004 55 2.38 17,435,000
13 원화예금 KRD010010001 13,890,399 1.9 13,890,399
14 SKBS KR7302440003 276 1.8 13,192,800
15 ST Pharm KR7237690003 131 1.67 12,248,500
16 Celltrionph KR7068760008 210 1.54 11,277,000
17 HANALL BIOPHARMA KR7009420001 368 1.51 11,076,800
18 CLASSYS KR7214150005 182 1.3 9,536,800
19 Hanmi Science KR7008930000 212 1.23 9,020,600
20 SEEGENE KR7096530001 334 1.17 8,567,100
21 GC Corp KR7006280002 57 1.03 7,512,600
22 HK inno.N KR7195940002 148 0.98 7,200,200
23 MedyTox KR7086900008 57 0.93 6,811,500
24 DAEWOONG PHARM KR7069620003 47 0.88 6,462,500
25 Pharmicell KR7005690003 583 0.87 6,348,870
26 CHA Biotech KR7085660009 556 0.8 5,865,800
27 L&C BIO KR7290650001 173 0.73 5,345,700
28 Binex KR7053030003 300 0.67 4,902,000
29 EuBio KR7206650004 324 0.61 4,435,560
30 WONTECH KR7336570007 448 0.6 4,430,720
31 ShinpoongPharm KR7019170000 345 0.6 4,364,250
32 DongKook Pharm KR7086450004 244 0.57 4,167,520
33 HLBPHARMA KR7047920004 290 0.54 3,958,500
34 DENTIUM KR7145720009 69 0.54 3,981,300
35 SD Biosensor KR7137310009 364 0.51 3,716,440
36 BIONEER KR7064550007 231 0.45 3,270,960
37 SELVAS AI KR7108860008 247 0.44 3,201,120
38 BioPlus KR7099430001 432 0.36 2,600,640
39 Huons Global KR7084110006 57 0.35 2,570,700
40 T&L KR7340570001 48 0.35 2,582,400
41 CUREXO KR7060280005 302 0.34 2,518,680
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.